Retina Macula Institute

Torrance, California 90503

2 studies enrolling now · 9 studies all time

What they study most

Diabetic Macular Edema, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, Macular Degeneration, Macular Edema, Neovascular Age Related Macular Degeneration, Non-Infectious Uveitis, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Retinal Vein Occlusion

Studies at this site

• A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — Recruiting now
• A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio — Recruiting now
• Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert — Completed
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema — Completed
• Study Investigating OCT, Multifocal ERG, and Microperimetry in Monthly Versus PRN Ranibizumab in Neovascular Age-Related Macular Degeneration — Completed
• An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy — Stopped early
• Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. — Completed
• Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study — Completed
• Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study — Withdrawn before enrolling